Search Constraints
Search Results
Select an image to start the slideshow
Studying the roles of SMARCB1 mutations in pediatric solid tumor cell lines
1 of 11
Studying the combination of CAR T cells and ICI for treatment of Melanoma
2 of 11
Characterizing the role of recurrent histone H3 mutations in cancer initiation
3 of 11
LCMT-1 is a negative regulator of inflammation and cancer-related signaling pathways
4 of 11
Evaluation of tumor membrane vesicle (TMV) vaccine immunotherapy in a HER2+ TUBO murine breast cancer model
5 of 11
DNA Methylation of CD4+ T-cells Reveals Association of ITGB7 in Pediatric Crohn’s Disease
6 of 11
Dynamic Expression Patterns of PRAP1 During Murine Gestation
7 of 11
Investigating the Roles of ACLY in Multiple Myeloma Biology and Drug Sensitivity
8 of 11
Induction of anti-tumor immunity by vaccine immunotherapy in murine lung cancer models
9 of 11
Graft versus Host Disease and Donor T cell Activation Is Limited by Vasoactive Intestinal Peptide Synthesis by Host Non-hempatopoietic Cells
10 of 11
Vasoactive Intestinal Peptide Antagonist Enhances T cell Proliferation and Synergizes with PD-1 Antibodies to Promote Anti-Melanoma T cell Immune Responses
11 of 11